Skip to main content

Advertisement

Table 2 MBC/MFC in µg/ml of synthesized indole hybridized diazenyl derivatives (DS1DS21)

From: Indole hybridized diazenyl derivatives: synthesis, antimicrobial activity, cytotoxicity evaluation and docking studies

Compound E. coli S. aureus S. enterica B. subtilis K. pneumonia A. niger A. fumigatus
MBC/MFC (µg/ml)
 DS-1 125 125 62.5 125 7.81 125 125
 DS-2 16.25 125 15.62 125 62.5 125 62.5
 DS-3 31.25 62.5 31.25 62.5 31.25 125 62.5
 DS-5 31.25 125 62.5 125 15.62 125 125
 DS-6 3.90 31.25 31.25 62.5 7.81 125 125
 DS-7 31.25 125 31.25 125 16.25 125 125
 DS-10 31.25 125 62.5 125 7.81 125 125
 DS-11 62.5 62.5 125 125 31.25 125 125
 DS-13 3.90 62.5 62.5 125 15.62 125 125
 DS-14 7.81 62.5 7.81 62.5 3.90 125 125
 DS-15 125 31.25 31.25 62.5 31.25 125 125
 DS-16 62.5 125 62.5 125 31.25 125 125
 DS-17 15.62 62.5 62.5 62.5 15.62 125 125
 DS-19 62.5 31.25 62.5 125 15.62 125 125
 DS-20 7.81 62.5 31.25 125 15.62 125 125
 DS-21 7.81 62.5 31.25 62.5 7.81 125 125
 CFT 15.62 31.25 31.25 15.62 3.90
 CPR 31.25 62.5 31.25 31.25 7.81
 FLU 125 125
  1. CFT cefotaxime, CPR ciprofloxacin, FLU fluconazole